Showing results (161-170 of 377) with videos related to
Sort By:
Pageof 38
Women'S Health (London, England)|April 20, 2021
Introducing a low-risk breast screening pathway into the NHS Breast Screening Programme: Views from healthcare professionals who are delivering risk-stratified screeningVictoria G Woof, Lorna McWilliams, Louise S Donnelly, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 2, 2009
Eligibility for magnetic resonance imaging screening in the United Kingdom: effect of strict selection criteria and anonymous DNA testing on breast cancer incidence in the MARIBS StudyD Gareth R Evans, Fiona Lennard, Linda J Pointon, et al.Journal of Medical Genetics|February 28, 2018
Penetrance estimates for BRCA1, BRCA2 (also applied to Lynch syndrome) based on presymptomatic testing: a new unbiased method to assess risk?D Gareth Evans, Emma Woodward, Elaine F Harkness, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2015
Estrogen Receptor Expression in 21-Gene Recurrence Score Predicts Increased Late Recurrence for Estrogen-Positive/HER2-Negative Breast CancerMitch Dowsett, Ivana Sestak, Richard Buus, et al.Journal of the National Cancer Institute|April 13, 2011
Tamoxifen-induced reduction in mammographic density and breast cancer risk reduction: a nested case-control studyJack Cuzick, Jane Warwick, Elizabeth Pinney, et al.BJC Reports|December 18, 2024
Long term follow-up of women treated for screen detected atypical ductal hyperplasia or lobular neoplasia in a large UK screening centreNicole L Brown, Susan Pritchard, Elaine F Harkness, et al.Journal of Medical Genetics|April 12, 2024
Pathogenic variant detection rate varies considerably in male breast cancer families and sporadic cases: minimal additional contribution beyond BRCA2, BRCA1 and CHEK2D Gareth Evans, George J Burghel, Sacha J Howell, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 9, 2005
Evidence for an association between compound heterozygosity for germ line mutations in the hemochromatosis (HFE) gene and increased risk of colorectal cancerJames P Robinson, Victoria L Johnson, Pauline A Rogers, et al.Clinical Endocrinology|February 21, 2004
Genetic analysis of mitochondrial complex II subunits SDHD, SDHB and SDHC in paraganglioma and phaeochromocytoma susceptibilityDewi Astuti, Niki Hart-Holden, Farida Latif, et al.British Journal of Cancer|May 9, 2018
Psychological impact of providing women with personalised 10-year breast cancer risk estimatesDavid P French, Jake Southworth, Anthony Howell, et al.Pageof 38